Covaxin
Indian envoy in Bangladesh now pushes for Covaxin
With the supply of Covid vaccine Covishield disrupted, Indian High Commissioner in Dhaka Vikram Doraiswami is now pushing for another option – Covaxin produced indigenously by his country.
Amid high domestic demand, the Serum Institute of India – which has been manufacturing the Oxford-Astrazeneca vaccine Covishield – has failed to keep its supply commitments to Bangladesh.
Doraiswamy said India was ready not only for trials of Covaxin in Bangladesh, but also for co-production, Dhaka Tribune said.
Covaxin has been developed on Indian soil by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV).
Doraiswami reiterated that for Covaxin, there is also an offer to co-produce, which remains on the table.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
